Changing the paradigm for high-dose pulmonary drug delivery.

Nob Hill Therapeutics is developing new technologies and therapies for lung-related diseases that can’t be effectively treated today. Their new drug inhalation device platform can deliver drugs to the lungs with higher efficiency and deeper into the lower respiratory tract without patient coordination. Nob Hill is also working on drug-device combination products that will serve as point-of-care for the technology.